Tag: Organoid
University of Birmingham Supports New Tumor Organoid Biobank Revealing Genetic Weaknesses in Cancer
Tumor organoid biobank: Researchers developed 256 patient-derived organoids representing five cancer types for biomedical research.
Gene dependency mapping: CRISPR screening identified genes that...
University of Auckland Secures $350,000 Boost for Cancer Research
Major Investment: Li Family Trust funding supports seven “bold and important” cancer research projects with $50,000 grants each.
Equity at the Core: Research...
An Organoid Model Of The Human Midbrain
In Parkinson’s disease dopaminergic neurons are irrecoverably lost from the midbrain resulting in slowed movement, tremors and other symptoms. Dopamine augmentation is the main...
A Living Biobank Of Non-Small Cell Lung Cancer Organoids
Globally, cancer of the lung is the most common cause of
cancer related mortality. It is also the most commonly diagnosed. 3D patient derived
organoids provide...
New Alzheimer’s Disease Organoids Enable Drug Discovery
Scientists at Scripps Research have reported for the first
time that Alzheimer’s patient-derived stem cells, which are engineered to
become “mini-brains” for lab research. The organoids...
New Papers Discuss The Science And Ethics Of Human Brain Organoids
Research involving the transplantation of human “mini-brains”—known as brain organoids—into animals to study disease can provide crucial insight’s into disease. Medical ethicist’s have raised...
Crown Bioscience Teams Up With HUB To Launch Tumor Organoid Drug Development Platform
Crown Bioscience has launched a new tumor organoid drug
development platform with the potential to significantly improve the
predictivity and speed of preclinical drug discovery. Independently founded...
MIMETAS And Hubrecht Organoid Technologies Partner To Market Organoids-On-A-Chip
MIMETAS and Hubrecht Organoid Technologies (HUB) have
entered into a strategic collaboration to market organoid models on a Chip. The
agreement includes a license to MIMETAS...
A:Head Bio AG Incorporated To Use Cerebral Organoids For CNS Drug Discovery
a:head bio AG, an Austrian biotech company focused on the
development of next generation therapeutics for the treatment of brain
disorders based on human cerebral organoids...
Proteostasis Therapeutics Contributes To HIT-CF Europe Cystic Fibrosis Organoid Drug Screens
Proteostasis Therapeutics, Inc., has announced that it has been invited to join the HIT-CF Europe, a pan European strategic initiative which seeks to validate...



















